Literature DB >> 4052276

Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.

M A Brown, R M Norris, P F Barnaby, G G Geary, P W Brandt.   

Abstract

Left ventricular function and exercise capacity were assessed in 79 patients randomised to receive intravenous and oral propranolol (n = 44) or conventional therapy (n = 35) within four hours of onset of their first myocardial infarction. Cineangiocardiography and exercise testing were performed four weeks after infarction to allow for maximum recovery of myocardial function. Left ventriculography showed no improvement in ejection fraction or preservation of regional contractile function in patients treated with propranolol compared with controls. A trend towards smaller end diastolic volumes was seen in the propranolol group (mean (SD) 151(42) ml) compared with controls (167(42) ml). Exercise duration and frequency of angina were not significantly different in the two groups. It is concluded that limitation of infarct size by propranolol does not lead to a significant improvement in ventricular systolic function, although left ventricular dilatation may be reduced. These findings are consistent with the known effect of early intravenous beta blockade which limits infarct size by preservation of subepicardial myocardium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052276      PMCID: PMC481909          DOI: 10.1136/hrt.54.4.351

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study.

Authors:  J A Erlebacher; J L Weiss; L W Eaton; C Kallman; M L Weisfeldt; B H Bulkley
Journal:  Am J Cardiol       Date:  1982-04-01       Impact factor: 2.778

2.  The relative role of subendocardium and subepicardium in left ventricular mechanics.

Authors:  H N Sabbah; M Marzilli; P D Stein
Journal:  Am J Physiol       Date:  1981-06

3.  Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts.

Authors:  R M Norris; N L Sammel; E D Clarke; P W Brandt
Journal:  Br Heart J       Date:  1980-06

4.  Effects of acebutolol on myocardial infarct extension: a randomized electrocardiographic, enzymatic and angiographic study.

Authors:  I Azancot; P Lorente; G Georgiopoulos; P Beaufils; C Masquet; Y Baudouy; R Slama
Journal:  Circulation       Date:  1982-11       Impact factor: 29.690

5.  Estimation of acute myocardial infarct size in man by serum CK-MB measurements.

Authors:  P Grande; B F Hansen; C Christiansen; J Naestoft
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

6.  Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol.

Authors:  N L Sammel; R M Norris; C F Hughes; R N Johnson; N G Ashton; R L Elliott
Journal:  Cardiovasc Res       Date:  1983-01       Impact factor: 10.787

7.  Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol.

Authors:  R M Norris; P F Barnaby; M A Brown; G G Geary; E D Clarke; R L Logan; D N Sharpe
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

8.  Myocardial infarct size and location in relation to the coronary vascular bed at risk in man.

Authors:  J T Lee; R E Ideker; K A Reimer
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

9.  Comparison of enzymic with cineangiocardiographic estimations of myocardial infarct size.

Authors:  N L Sammel; J G Stuckey; P W Brandt; R M Norris
Journal:  Br Heart J       Date:  1980-06

10.  Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog.

Authors:  R D Reynolds; W E Burmeister; R J Gorczynski; D D Dickerson; M P Mathews; R J Lee
Journal:  Cardiovasc Res       Date:  1981-07       Impact factor: 10.787

View more
  1 in total

1.  Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

Authors: 
Journal:  BMJ       Date:  1992-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.